Intriguingly, upregulation of PHLDB3 was significantly correlated with rare TP53 mutations in breast cancer, breast invasive carcinoma and esophageal carcinoma as revealed by the analysis of cBioPortal databases25, 26 (Fig. 3d,e). This evidence concerns the gene PHLDB3 and carcinoma of esophagus.